Get the Stockscreener App
0.8999
0.64%
-0.016
DSS Inc stock is traded at $0.8999, with a volume of 4,651.
It is down -0.64% in the last 24 hours and up +3.41% over the past month.
Document Security Systems, Inc., through its subsidiaries, develops, manufactures, markets, and sells paper and plastic products to protect information from unauthorized scanning, copying, and digital imaging in the United States and internationally. The company's DSS Packaging and Printing Group segment produces custom paperboard packaging products for pharmaceutical, beverage, photo packaging, toy, specialty foods, direct marketing, and other industries. Its products include security paper, vital records, prescription papers, birth certificates, receipts, manuals, identification materials, entertainment tickets, secure coupons, parts tracking forms, brochures, direct mailing pieces, catalogs, business cards, etc. This segment also offers secure and commercial printing services for end-user customers, as well as technical support for its technology licensees. Its DSS Plastics Group segment manufactures laminated and surface printed cards, including magnetic stripes, bar codes, holograms, signature panels, invisible ink products, micro fine printing and biometric products, guilloche patterns, ID cards, event badges, and driver's licenses. The company's DSS Digital Group segment provides data center centric solutions to businesses and governments through the cloud. It also develops an iPhone based application that integrates its traditional optical deterrent technologies into proprietary digital data security based solutions for brand protection and product diversion prevention. Its DSS Technology Management segment acquires or develops patented technology or intellectual property assets. The company markets its primary anti-counterfeiting products and technologies under the AuthentiGuard name. Document Security Systems, Inc. was founded in 1984 and is headquartered in Rochester, New York.
See More
Previous Close:
$0.9159
Open:
$0.91
24h Volume:
4,651
Relative Volume:
0.16
Market Cap:
$8.55M
Revenue:
$20.69M
Net Income/Loss:
$-44.34M
P/E Ratio:
-0.1424
EPS:
-6.32
Net Cash Flow:
$-7.51M
1W Performance:
+0.00%
1M Performance:
+3.41%
6M Performance:
+1.11%
1Y Performance:
-48.11%
1-Day Range:
$0.8999
$0.9159
1-Week Range:
$0.7899
$1.03
52-Week Range:
$0.72
$1.75
DSS Inc Stock (DSS) Company Profile
Name
DSS Inc
Sector
Industry
Phone
585-325-3610
Address
200 Canal View Boulevard, Suite 300, Rochester, NY
Compare DSS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DSS
DSS Inc
|
0.8999 | 8.55M | 20.69M | -44.34M | -7.51M | -6.32 |
|
IP
International Paper Co
|
47.02 | 25.14B | 19.90B | 396.00M | -5.00M | 1.17 |
|
SW
Smurfit Westrock Plc
|
43.20 | 22.65B | 25.80B | 571.00M | -106.12M | 1.44 |
|
AMCR
Amcor Plc
|
9.295 | 21.17B | 13.55B | 769.00M | 674.00M | 0.531 |
|
PKG
Packaging Corp Of America
|
189.29 | 17.75B | 8.54B | 861.90M | 528.80M | 9.56 |
|
BALL
Ball Corp
|
56.91 | 15.26B | 12.02B | 502.00M | 286.00M | 1.68 |
DSS Inc Stock (DSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-20 | Initiated | Aegis Capital | Buy |
| Jul-22-13 | Initiated | Dawson James | Buy |
DSS Inc Stock (DSS) Latest News
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth | DSS Stock News - GuruFocus
DSS reports Q1 EPS (55c) vs. (58c) last year - TipRanks
DSS, Inc. Reports Strong Q1 2025 Financial Results with 28% Revenue Growth and Significant Debt Reduction - Nasdaq
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth - GlobeNewswire
DSS Delivers Triple Win in Q1 2025: 28% Revenue Jump, $9.5M Asset Sale, and Major Debt Reduction - Stock Titan
The 7 Best Robinhood Stocks Under 2 Dollars To Buy For June 2025 - The Stock Dork
DSS, Inc. Interview To Air On Bloomberg U.S. On The RedChip Money Report® - Barchart.com
Market Watch Highlights: Impact BioMedical Inc (IBO) Ends on an Upturn Note at 0.61 - DWinneX
Market Resilience: Impact BioMedical Inc (IBO) Finishes Weak at 0.50, Down -2.92 - DWinneX
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Recei - GuruFocus
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings - The Globe and Mail
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., - GlobeNewswire
Closing Figures: Impact BioMedical Inc (IBO)’s Positive Finish at 0.42, Up 1.11 - DWinneX
The VA EHR modernization roadmap under the Trump administration - Federal News Network
DSS, Inc. sells $845,012 in Impact Biomedical stock By Investing.com - Investing.com UK
DSS, Inc. sells $845,012 in Impact Biomedical stock - Investing.com
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
DSS (NYSEAMERICAN:DSS) Share Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
DSS Inc. (DSS) reports earnings - Quartz
DSS Inc. sells $1.95 million worth of Impact Biomedical shares By Investing.com - Investing.com Canada
DSS Inc. sells $1.95 million worth of Impact Biomedical shares - Investing.com Australia
Impact BioMedical Inc. (IBO) reports earnings - Quartz
DSS, Inc. sells $249,408 in Impact Biomedical stock By Investing.com - Investing.com UK
DSS, Inc. sells $249,408 in Impact Biomedical stock - Investing.com
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
DSS announces sale of Celios to Impact BioMedical - MSN
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth - GlobeNewswire
Alset Inc. CEO Chan Heng Fai acquires $21,661 in common stock - MSN
DSS jumps on sale of Celios air purification business - MSN
Impact Biomedical Inc. Announces Acquisition of Celios®, 'Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality” - The Manila Times
Why is DSS offloading its innovative air purification tech? Inside the $1.15M strategic pivot - StockTitan
Alset Inc. CEO Chan Heng Fai acquires $21,661 in common stock By Investing.com - Investing.com South Africa
Alset Inc. CEO Chan Heng Fai Ambrose buys $294,149 in common stock - Investing.com India
DSS, Inc. Awards One Million Shares to Heng Fai Holdings Limited as Compensation under the 2020 Equity Incentive Plan - Armenian Reporter
DSS Inc Stock (DSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
DSS Inc Stock (DSS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DSS, INC. | 10% Owner |
May 27 '25 |
Sale |
0.54 |
45,400 |
24,530 |
0 |
| DSS, INC. | 10% Owner |
Apr 04 '25 |
Sale |
0.95 |
890,800 |
845,013 |
161,100 |
| DSS, INC. | 10% Owner |
Mar 21 '25 |
Sale |
3.30 |
499,800 |
1,649,540 |
0 |
| DSS, INC. | 10% Owner |
Mar 26 '25 |
Sale |
3.13 |
58,139 |
182,134 |
1,099,481 |
| DSS, INC. | 10% Owner |
Mar 27 '25 |
Sale |
2.50 |
47,681 |
119,255 |
1,051,800 |
| DSS, INC. | 10% Owner |
Mar 20 '25 |
Buy |
1.55 |
200 |
310 |
53,280 |
| DSS, INC. | 10% Owner |
Mar 20 '25 |
Sale |
4.68 |
53,280 |
249,350 |
0 |
| DSS, INC. | 10% Owner |
Dec 02 '24 |
Sale |
2.90 |
20 |
58 |
53,080 |
| Chan Heng Fai Ambrose | Director |
Dec 10 '24 |
Buy |
0.97 |
820,597 |
800,000 |
3,961,211 |
| Chan Heng Fai Ambrose | Director |
Dec 10 '24 |
Buy |
0.97 |
205,149 |
200,000 |
1,184,475 |
2.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):